This technology is an extracellular matrix-based bioadhesive in the form of a composition comprising an extracellular matrix-containing hydrogel and a gelatin hardener.
Existing tissue adhesives had limitations such as low adhesive strength or poor applicability.
This technology, with rheological properties similar to gelatin, exhibits flowability above 30℃, allowing for even application to the lesion site. It provides 2 to 6 times higher adhesive strength compared to fibrin glue, along with wound healing and tissue regeneration components.
US12337075B2